Brett Mahon to Risk Assessment
This is a "connection" page, showing publications Brett Mahon has written about Risk Assessment.
Connection Strength
0.021
-
Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
Score: 0.021